US Stock MarketDetailed Quotes

MRNA Moderna

Watchlist
  • 107.890
  • +3.430+3.28%
Close Apr 23 16:00 ET
  • 112.100
  • +4.210+3.90%
Pre 08:57 ET
41.31BMarket Cap-8750P/E (TTM)

About Moderna Company

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Company Profile

SymbolMRNA
Company NameModerna
Listing DateDec 7, 2018
Issue Price23.00
Founded2010
CEOMr. Stephane Bancel
MarketNASDAQ
Employees5600
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address200 Technology Square
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-714-6500

Company Executives

  • Name
  • Position
  • Salary
  • Stephane Bancel
  • Director and Chief Executive Officer
  • 17.07M
  • Kate Cronin
  • Chief Brand Officer
  • --
  • James M Mock
  • Chief Financial Officer and Principal Accounting Officer
  • 4.32M
  • Shannon Thyme Klinger
  • Chief Legal Officer and Corporate Secretary
  • 4.31M
  • Jerh Collins
  • Chief Technical Operations and Quality Officer
  • --
  • Brad Miller
  • Chief Information Officer
  • --
  • Tracey Franklin
  • Chief Human Resources Officer
  • --
  • Dr. Stephen Hoge, M.D.
  • President
  • 7.34M
  • Dr. Noubar B. Afeyan, PhD
  • Chairman of the Board
  • 663.52K
  • Elizabeth E. Tallett
  • Independent Director
  • 481.27K
  • Paul Sagan
  • Independent Director
  • 461.27K
  • Dr. Elizabeth G. Nabel, M.D.
  • Independent Director
  • 476.25K
  • Dr. Francois Nader, M.D.
  • Independent Director
  • 481.27K
  • Dr. Sandra J. Horning, M.D.
  • Independent Director
  • 481.27K
  • Dr. Robert S. Langer, Sc.D.
  • Independent Director
  • 461.27K
  • Stephen Berenson
  • Independent Director
  • 471.25K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg